News

EU drugs regulator to allow Novo Nordisk to include heart condition in Ozempic label
Novo Nordisk said on Monday the European drugs regulator will allow a label update for its diabetes drug Ozempic to include a ...
Novo Nordisk Stock Drops on Weight-Loss Data. Why Investors Have Doubts.
Novo Nordisk unveiled its latest data for a weight-loss drug candidate, but shares of the maker of Wegovy and Ozempic tumbled ...
Pharmabiz5h
CHMP recommends approval of Novo Nordisk’s Ozempic for peripheral arterial disease
CHMP recommends approval of Novo Nordisk’s Ozempic for peripheral arterial disease: Bagsværd, Denmark Wednesday, June 25, 2025, 15:00 Hrs [IST] Novo Nordisk, a leading global h ...
New Atlas2d
Ozempic maker announces not one, but three new weight-loss drugs
Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing ...
Novo Nordisk Stock Sinks as Latest Weight-Loss Drug Trial Disappoints
Novo Nordisk's U.S.-listed shares fell close to 6% Monday after the drugmaker revealed the latest results for a new ...
CNBCTV189h
Novo Nordisk launches blockbuster weight loss drug Wegovy in India
Wegovy is only approved for obesity in India. Novo Nordisk has no immediate plans to launch Ozempic for type 2 diabetes, ...
24/7 Wall St.5d
Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (June 2025)
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...
US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list
A federal judge has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's ...